Home Cart Sign in  
Chemical Structure| 1362154-70-8 Chemical Structure| 1362154-70-8

Structure of GNE-617
CAS No.: 1362154-70-8

Chemical Structure| 1362154-70-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GNE-617 is a potent NAMPT inhibitor with IC50 value of 5nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GNE-617

CAS No. :1362154-70-8
Formula : C21H15F2N3O3S
M.W : 427.42
SMILES Code : O=C(C1=CN2C(C=C1)=NC=C2)NCC3=CC=C(S(=O)(C4=CC(F)=CC(F)=C4)=O)C=C3
MDL No. :MFCD26960964
InChI Key :XRDVXQQZLHVEQZ-UHFFFAOYSA-N
Pubchem ID :68277611

Safety of GNE-617

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
IDH1wt and IDH1R132H glioblastoma cells 25 nM and 100 nM 48 or 96 hours To test the cytotoxicity of GNE-617 on IDH1wt and IDH1R132H glioblastoma cells. Results showed that GNE-617 significantly reduced metabolic activity after 48 hours and exhibited cytotoxicity to both cell types after 96 hours. PMC9143996
PC3 0.2 μM 96 hours To evaluate the anti-proliferative effects of GNE-617 in NAPRT1-deficient tumor cells, results showed that GNE-617 significantly reduced ATP levels and cell viability in PC3 cells. PMC3884523
MiaPaCa-2 0.2 μM 96 hours To evaluate the anti-proliferative effects of GNE-617 in NAPRT1-deficient tumor cells, results showed that GNE-617 significantly reduced ATP levels and cell viability in MiaPaCa-2 cells. PMC3884523
A549 200 nM 24, 48, 72 hours GNE-617 induces cell death, with partial activation of caspase-3 PMC4271207
Colo205 200 nM 24, 48, 72 hours GNE-617 induces cell death, with partial activation of caspase-3 PMC4271207
HCT116 200 nM 24, 48, 72 hours GNE-617 induces cell death, with partial activation of caspase-3 PMC4271207
Calu6 200 nM 24, 48, 72 hours GNE-617 induces cell death, no caspase-3 activation detected PMC4271207
HT1080 200 nM 24, 48, 72 hours GNE-617 induces cell death, no caspase-3 activation detected PMC4271207
PC3 200 nM 24, 48, 72 hours GNE-617 induces cell death, no caspase-3 activation detected PMC4271207
A549 0.4 μM 72 and 96 hours A549 cells reduced glycolysis and levels of di- and tri-nucleotides and modestly increased oxidative phosphorylation, but they were unable to activate AMPK due to a mutation in LKB1. However, A549 cells increased utilization of the Pentose Phosphate pathway (PPP) and had lower reactive oxygen species (ROS) levels than H1334 cells, indicating that A549 cells are better able to modulate an increase in oxidative stress. PMC7370470
NCI-H1334 0.4 μM 72 and 96 hours H1334 cells reduced glycolysis and levels of di- and tri-nucleotides and modestly increased oxidative phosphorylation, and they activated the stress kinase AMPK. PMC5053472
NCI-H441 0.4 μM 72 and 96 hours NCI-H441 cells showed intermediate sensitivity to GNE-617, with reduced NAD levels but less pronounced metabolic changes compared to sensitive cell lines. PMC5053472
LC-KJ 0.4 μM 72 and 96 hours LC-KJ cells were inherently resistant to GNE-617, with higher baseline levels of NADPH and a delayed reduction of NAD upon NAMPT inhibition. PMC5053472

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice NAPRT1-deficient tumor xenograft models Oral 1000 mg/kg, every 12 hours Every 12 hours for 3 days To evaluate the anti-tumor effects of GNE-617 in NAPRT1-deficient tumor xenograft models, results showed that GNE-617 induced tumor regression in multiple models and significantly reduced tumor NAD levels. PMC3884523

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.34mL

0.47mL

0.23mL

11.70mL

2.34mL

1.17mL

23.40mL

4.68mL

2.34mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories